Skip to main content
. 2025 Feb 17;2025:8276090. doi: 10.1155/adpp/8276090

Table 3.

Summary of the key mechanisms targeted by Z. lotus (L.) bioactive compounds.

Bioactive compound Mechanisms of action Impact on metabolism Impact on vascular function
Rutin - Inhibition of ACE
- Activation of insulin signaling (IR kinase activity, GLUT4 translocation)
- Inhibition of α-amylase and α-glucosidase
- Reduces the expression of G-6-Pase
- Decreases HMG-CoA
- Inhibits NOD-like receptor pyrin domain inflammasome pathways
- Reduces TNF-α and IFNγ
- Suppresses proinflammatory markers (TNF-α, MCP-1, IFNγ, IL-6, IL-2, and NF-κB)
- Suppressing the expression of NADPH oxidase 4.
- Reduces blood glucose levels
- Improves insulin sensitivity
- Reduces dyslipidemia (TC, TG, and LDL-C)
- Improved LPL and LCAT
- Reduces FBG, HbA1c
- Endothelium-dependent vasorelaxation through NO-guanylyl cyclase pathway, ATP-sensitive K+ channel activation
- Recovering NO generation
- Improves vascular reactivity and baroreflex sensitivity

Hyperin - Inhibition of α-glucosidase
- Inhibits α-amylase
- Upregulating the expression of PPARγ
- Inhibits NF-κB
- Reduces blood glucose levels and plasma lipids (TC, TG, and LDL-C)
- Improves insulin sensitivity
- Suppresses inflammation
-Endothelium-dependent and independent vasodilation through KCa channels and NO
- Increased nitric oxide bioavailability
- Suppression of chymase (Ang-II-forming enzyme)
- Reduces peripheral vascular resistance and coronary vessel medial thickness

Isoquercitrin - Inhibition of α-amylase
- Modulation of AMP-activated protein kinase (AMPK)
- Regulation of insulin signaling genes (IR, IRS-1, IRS-2, and PKB)
- Inhibition of Na+/K+-ATPase activity
- Attenuates NF-κB and TNF-α expression
- Improves blood glucose control
- Enhances insulin secretion
- Reduces dyslipidemia
- Inhibits adipogenesis.
- Suppression of oxidative stress, inflammation, and mitochondrial dysfunction
- Endothelium-dependent vasodilation
- Increase in nitric oxide and hydrogen sulfide in endothelial cells
- Bioavailability enhancement of bradykinin and prostaglandin I2
- Reduction in vascular resistance
- Protects endothelial cells by upregulating antiapoptotic proteins (Bcl-2) and downregulating proapoptotic proteins (p53, Bax, and caspase 3)
- Exhibits potent diuretic effects by increasing Na+ excretion while maintaining K+ balance

Resveratrol - Activation of SIRT1 and AMPK
- Modulation of PPARγ and inflammatory pathways
- Inhibition of α-glucosidase and lipid metabolism enzymes
- Improves FBG and HbA1c and insulin sensitivity
- Reduces glucose and lipid levels
- Decreases adipogenesis
- Endothelial NO generation via eNOS activation
- Vasodilation through improved NO bioavailability
- Suppression of Gi protein signaling in vascular smooth muscle